Lysosomal Storage Diseases Therapeutics Market: Global Impact of...

ha aggiunto una foto Health

2025-12-08 09:59:39 -

Lysosomal Storage Diseases Therapeutics Market: Global Impact of Orphan Drug Designation Policies

The Genesis and Incentives of the US Orphan Drug Act The US Orphan Drug Act (ODA), enacted in 1983, was a landmark piece of legislation designed to incentivize pharmaceutical companies to develop treatments for rare diseases (defined as those affecting fewer than 200,000 people in the US). For the Lysosomal Storage Diseases Therapeutics Market, the ODA has been foundational, offering essential...

0 Commenti 0 condivisioni 114 Views 0 Anteprima